Literature DB >> 33263654

Surgical results of remnant gastric cancer treatment.

Marcus Fernando Kodama Pertille Ramos1, Maria Claudia Machado Pereira2, Yara Souza Oliveira2, Marina Alessandra Pereira1, Leandro Cardoso Barchi1, Andre Roncon Dias1, Bruno Zilberstein1, Ulysses Ribeiro Junior1, Ivan Cecconello1.   

Abstract

BACKGROUND: remnant gastric cancer (RGC) develops five years or later after previous resection for benign or malignant lesion. The treatment is performed through completion total gastrectomy (CTG) with radical lymphadenectomy. Some reports consider this procedure may be associated with higher rates of morbidity and mortality.
OBJECTIVE: to evaluate surgical results and survival after CTG in patients with RGC.
METHODS: 54 patients who underwent CTG between 2009 and 2019 were included in the study. As a comparison group 215 patients with primary gastric cancer (PGC) who underwent total gastrectomy (TG) in the same period were selected.
RESULTS: among the initial characteristics, age (68.0 vs. 60.5; p<0.001), hemoglobin values (10.9 vs. 12.3; p<0.001) and body mass index (22.5 vs. 24.6; p=0.005) were different between the RGC and PGC groups, respectively. The most frequent postoperative complications were related to pulmonary complications, infection and fistula in both groups. There was a higher incidence of esophagojejunal fistula in the CTG group (14.8% vs 6.5%, p=0.055). Perioperative mortality was higher in RGC patients (9.3% vs. 5.1%), but without significance (p=0.329). Hospital length of stay, postoperative complications graded by the Clavien-Dindo classification, mortality at 30 and 90 days were not different between groups. There was no significant difference in disease-free and overall survival between RGC and PGC groups.
CONCLUSION: despite previous reports, surgical results and survival were similar between groups. Higher risk of esophagojejunal fistula must be considered.

Entities:  

Year:  2020        PMID: 33263654     DOI: 10.1590/0100-6991e-20202703

Source DB:  PubMed          Journal:  Rev Col Bras Cir        ISSN: 0100-6991


  2 in total

1.  Knockdown of RREB1 inhibits cell proliferation via enhanced p16 expression in gastric cancer.

Authors:  Qi Gao; Yunhua Wu; Chaoxiang Lu; Wang Kai; Weike Xie; Qi Wang; Lei Wang; Shiqi Liu; Yongkang Pan
Journal:  Cell Cycle       Date:  2021-10-19       Impact factor: 5.173

2.  Impact of intra-abdominal insufflation pressure on gas leakage occurring during laparoscopy.

Authors:  Jeffrey Dalli; Tess Montminy; Makenzie Ferguson; Mohammad Faraz Khan; Kevin Nolan; Ronan A Cahill
Journal:  Surg Endosc       Date:  2022-05-03       Impact factor: 3.453

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.